Paravalvular leak

There are 4 papers on paravalvular leak in aging research: 1 trial and 3 observational studies in people.

Disease

4 papers study it3 more mention it1 finding

1 new paper in 30 daysSee all 7 papers on paravalvular leak

  • Human trial1
  • Humans3

Interventions

1

Tirzepatide

downin humans1

1 study
  1. Tirzepatide decreases paravalvular leak in obese patients undergoing transfemoral TAVR (10.7% vs 25.3%; p = 0.006).

    “and ≥ mild PVL (10.7% vs 25.3%, p = 0.006) at 6 months”

    Human trialin obese patients undergoing transfemoral TAVR6 months

    Tirzepatide therapy reduces subclinical leaflet thrombosis and paravalvular leak after transcatheter aortic valve replacement in obese patients: The TAVR-MET trial

    Cardiovascular revascularization medicine : including molecular interventions

More on Tirzepatide

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 03 papers in 12 months